Asax Co Ltd
TSE:8772
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
|
US |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Walmart Inc
NYSE:WMT
|
Retail
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
648
852
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
Johnson & Johnson
NYSE:JNJ
|
US | |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US | |
Bank of America Corp
NYSE:BAC
|
US | |
Mastercard Inc
NYSE:MA
|
US | |
UnitedHealth Group Inc
NYSE:UNH
|
US | |
Exxon Mobil Corp
NYSE:XOM
|
US | |
Pfizer Inc
NYSE:PFE
|
US | |
Palantir Technologies Inc
NYSE:PLTR
|
US | |
Nike Inc
NYSE:NKE
|
US | |
Visa Inc
NYSE:V
|
US | |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN | |
3M Co
NYSE:MMM
|
US | |
JPMorgan Chase & Co
NYSE:JPM
|
US | |
Coca-Cola Co
NYSE:KO
|
US | |
Walmart Inc
NYSE:WMT
|
US | |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Asax Co Ltd
Cost of Revenue
Asax Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
Asax Co Ltd
TSE:8772
|
Cost of Revenue
-ÂĄ581.7m
|
CAGR 3-Years
17%
|
CAGR 5-Years
20%
|
CAGR 10-Years
12%
|
||
G
|
GFA Co Ltd
TSE:8783
|
Cost of Revenue
-ÂĄ2.1B
|
CAGR 3-Years
8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
A
|
Aruhi Corp
TSE:7198
|
Cost of Revenue
-ÂĄ4.1B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Mortgage Service Japan Ltd
TSE:7192
|
Cost of Revenue
-ÂĄ2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
Asax Co Ltd
Glance View
Asax Co., Ltd. engages in the provision of real estate mortgage loan services. The company is headquartered in Shibuya-Ku, Tokyo-To and currently employs 74 full-time employees. The company went IPO on 2007-02-14. The real estate equity loans business is mainly engaged in the financing of real estate related business. The real estate sales business is engaged in the acquisition and sale of real estate. The credit guarantee business is engaged in the credit guarantee business for real estate secured loans made by financial institutions.
See Also
What is Asax Co Ltd's Cost of Revenue?
Cost of Revenue
-581.7m
JPY
Based on the financial report for Sep 30, 2024, Asax Co Ltd's Cost of Revenue amounts to -581.7m JPY.
What is Asax Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
12%
Over the last year, the Cost of Revenue growth was -7%. The average annual Cost of Revenue growth rates for Asax Co Ltd have been 17% over the past three years , 20% over the past five years , and 12% over the past ten years .